UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): May 3, 2013
Commission File No. 001-12575
UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)
| UTAH | 87-0342734 |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
7043 South 300 West
Midvale, Utah 84047
Address of principal executive offices
| Registrant's telephone number: | (801) 566-1200 |
ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
On May 3, 2013 at the annual meeting, shareholders of the Company approved or indicated their preference on the following matters submitted to them for consideration:
| Elected Barbara A. Payne as a director of the Company: |
| | For | 2,849,261 | Withheld | 141,750 | | |
| | | | | | | |
| Approved the 2013 Employees’ and Directors’ Incentive Plan: |
| | For | 2,304,518 | Against | 674,497 | Abstentions | 11,996 |
| | | | | | | |
Ratified the selection of Jones Simkins LLC as the Company’s independent public accounting firm for the year ended December 31, 2013: |
| | For | 3,463,280 | Against | 13,504 | Abstentions | 7,653 |
| | | | | | | |
| Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion: |
| | For | 2,846,990 | Against | 83,180 | Abstentions | 60,841 |
Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | UTAH MEDICAL PRODUCTS, INC. |
| | REGISTRANT |
| | |
| | |
Date: 5/07/2013 | By: /s/ Kevin L. Cornwell |
| | Kevin L. Cornwell |
| | CEO |
